A good growth outlook is seen for Rani Therapeutics Holdings Inc (RANI) Stock by analysts
BTIG Research raised the price target for the Rani Therapeutics Holdings Inc (NASDAQ:RANI) stock to “a Buy”. The rating was released on April 17, 2023, according to finviz. The research report from H.C. Wainwright has initiated the stock to Buy, with a price target set at $22. The stock was initiated by Wedbush, who disclosed […]